Congratulations to our Aspen Aspire Leadership Signature Programme graduates from our Gqeberha and East London sites on successfully completing their NQF 6 Advanced Certificate in Management through Milpark Business School.
Congratulations to our Aspen Aspire Leadership Signature Programme graduates from our Gqeberha and East London sites on successfully completing their NQF 6 Advanced Certificate in Management through Milpark Business School.
Aspen Oss has been awarded an EcoVadis Gold Medal, placing the site in the top 5% globally in its industry for sustainability performance. EcoVadis assesses organisations across environment, labour & human rights, ethics, and responsible business practices.
This month, the spotlight is not on systems or infrastructure, but on the person who brings them to life every day — Nicolas Lachèvre, Work‑Study Student in IT Operations at Aspen NDB.
The Two Oceans Marathon once again brought together determination, camaraderie and athletic excellence—and Aspen Athletics Club delivered across both race days in Cape Town.
Lorraine Hill, Aspen’s Group COO, attended the World Bank & IMF Spring Meetings in Washington, following an invitation from the IFC. Health and access featured strongly, including the World Bank’s Health Works initiative to expand quality, affordable healthcare by 2030.
The Australian Pharmacy Professional Conference & Trade Exhibition (APP) once again brought together nearly 8,000 pharmacy professionals from across Australia — pharmacists, interns, students, assistants, and industry partners — for three days filled with learning, networking, and professional development. This year’s event was especially memorable as Aspen Australia celebrated their 25-year anniversary.
The Alphamed Work Journal series captures the insights, experiences, and reflections of Aspen Global Incorporated (AGI) colleagues participating in international upskilling programmes.
Aspen Pharma Ireland Limited (“Aspen”), a subsidiary of Aspen Pharmacare Holdings Limited, has entered into an exclusive licensing agreement (“Agreement”) with UK-based specialist pharmaceutical company Viramal Limited (“Viramal”) for an innovative Women’s Health portfolio. Under the agreement, Aspen will have exclusive rights to launch and commercialize selected products from Viramal’s portfolio in Europe, the Middle East, Brazil and Mexico.
Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.
